MassMutual Private Wealth & Trust’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.93K Hold
338
﹤0.01% 1688
2026
Q1
$2.51K Buy
338
+22
+7% +$231 ﹤0.01% 1916
2025
Q4
$3.72K Hold
316
﹤0.01% 1803
2025
Q3
$2.44K Sell
316
-37
-10% -$259 ﹤0.01% 1929
2025
Q2
$2.58K Buy
353
+128
+57% +$1.03K ﹤0.01% 1879
2025
Q1
$2.13K Hold
225
﹤0.01% 1894
2024
Q4
$3.71K Sell
225
-100
-31% -$1.55K ﹤0.01% 1637
2024
Q3
$4.79K Buy
325
+100
+44% +$1.56K ﹤0.01% 1399
2024
Q2
$3.12K Sell
225
-103
-31% -$1.46K ﹤0.01% 1486
2024
Q1
$5.16K Sell
328
-16
-5% -$247 ﹤0.01% 1268
2023
Q4
$5.57K Buy
344
+53
+18% +$867 ﹤0.01% 1210
2023
Q3
$3.58K Sell
291
-29
-9% -$431 ﹤0.01% 1350
2023
Q2
$5.14K Buy
320
+287
+870% +$4.73K ﹤0.01% 1201
2023
Q1
$575 Hold
33
﹤0.01% 1654
2022
Q4
$0 Sell
33
-153
-82% -$1.43K ﹤0.01% 1776
2022
Q3
$2K Buy
+186
New +$1.85K ﹤0.01% 1247
2022
Q1
Sell
-19
Closed -$400 1597
2021
Q4
$1K Buy
+19
New +$744 ﹤0.01% 1263

Other funds holding NEO

MassMutual Private Wealth & Trust's NEO Position: Q2 2026 in Review

MassMutual Private Wealth & Trust held its NeoGenomics (NEO) position steady in Q2 2026 at 338 shares worth $4.93K. The position accounts for ﹤0.01% of the portfolio, ranked #1688.

MassMutual Private Wealth & Trust first reported a position in NEO in Q4 2021 and has held it in 17 quarters since. The position peaked at $5.57K in Q4 2023. 60 funds tracked by Wall St. Rank hold NEO as of Q2 2026.

  • MassMutual Private Wealth & Trust held 338 shares of NeoGenomics worth $4.93K as of Q2 2026.
  • MassMutual Private Wealth & Trust left its NeoGenomics share count unchanged in Q2 2026.
  • NeoGenomics made up ﹤0.01% of MassMutual Private Wealth & Trust's portfolio in Q2 2026, its #1688 holding.
  • MassMutual Private Wealth & Trust first reported a position in NeoGenomics in Q4 2021 and has held it in 17 quarters since.
  • MassMutual Private Wealth & Trust's NeoGenomics position peaked at $5.57K in Q4 2023.
  • 60 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.

Based on MassMutual Private Wealth & Trust's 13F filing for Q2 2026, filed 2 Jul 2026.